دورية أكاديمية
أعرض في EDS

The impact of chronic kidney disease on long-term outcomes following semi-urgent and elective percutaneous coronary intervention.

التفاصيل البيبلوغرافية
العنوان: The impact of chronic kidney disease on long-term outcomes following semi-urgent and elective percutaneous coronary intervention.
المؤلفون: Soh RY; Internal Medicine Residency, National University Health System., Sia CH; Department of Cardiology, National University Heart Centre.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore., Lau RH; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore., Ho PY; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore., Timothy NY; National University Health System, University Medicine Cluster, Singapore, Singapore., Ho JS; School of Clinical Medicine, University of Cambridge, Cambridge, UK., Kaur H; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore., Sim HW; Department of Cardiology, National University Heart Centre., Yeo TC; Department of Cardiology, National University Heart Centre.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore., Tan HC; Department of Cardiology, National University Heart Centre., Chan MY; Department of Cardiology, National University Heart Centre.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore., Loh JP; Department of Cardiology, National University Heart Centre.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore.
المصدر: Coronary artery disease [Coron Artery Dis] 2021 Sep 01; Vol. 32 (6), pp. 517-525.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9011445 Publication Model: Print Cited Medium: Internet ISSN: 1473-5830 (Electronic) Linking ISSN: 09546928 NLM ISO Abbreviation: Coron Artery Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: London : Lippincott Williams & Wilkins
Original Publication: Philadelphia, Pa. : Current Science, c1990-
مواضيع طبية MeSH: Percutaneous Coronary Intervention*, Coronary Artery Disease/*surgery , Renal Insufficiency, Chronic/*complications, Aged ; Coronary Artery Disease/mortality ; Female ; Glomerular Filtration Rate ; Humans ; Male ; Middle Aged ; Renal Insufficiency, Chronic/mortality ; Renal Insufficiency, Chronic/therapy ; Retrospective Studies ; Risk Factors
مستخلص: Introduction: The effects of chronic kidney disease (CKD) on outcomes in patients undergoing semi-urgent and elective percutaneous coronary intervention (PCI) are unclear. This study aims to investigate impact of CKD on long-term outcomes of this population.
Methods: This was a retrospective cohort study of patients who underwent semi-urgent and elective PCI from 1 January 2014 to 31 December 2015 at a tertiary academic center. They were stratified into five groups - group 1 [estimated glomerular filtration rate (eGFR) ≥90 ml/min/1.73m2], group 2 (eGFR 60-89 ml/min/1.73m2), group 3 (eGFR 30-59 ml/min/1.73 m2), group 4 (eGFR <30 ml/min/1.73m2), and group 5 (dialysis). Demographics, risk factors in relation to endpoints of all-cause mortality, contrast-induced nephropathy (CIN), three-point major adverse cardiac events (MACE) (cardiac death, subsequent myocardial infarction, subsequent stroke), and four-point MACE (including target lesion revascularization) were analyzed.
Results: One thousand six hundred nine patients were included. Advanced CKD patients were more likely to be female and older, with higher prevalence of co-morbidities. Compared to group 1, group 4 patients were associated with increased risk of three-point [adjusted hazard ratio (aHR) 1.94, 95% confidence interval (CI): 1.06-3.55; P = 0.031] and four-point MACE (aHR 2.15, 95% CI: 1.21-3.80; P = 0.009). However, higher contrast volume usage [odds ratio (OR) 2.20, 95% CI: 1.04-4.68; P = 0.040) was associated with increased CIN risk but not reduced eGFR (OR 1.62, 95% CI: 0.57-4.65; P = 0.369).
Conclusion: Advanced CKD patients undergoing PCI were associated with higher co-morbid burden. Despite adjustments for co-morbidities, these patients had higher mortality and worse cardiovascular outcomes at 3 years following contemporary PCI.
(Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
References: Cai Q, Mukku VK, Ahmad M. Coronary artery disease in patients with chronic kidney disease: a clinical update. Curr Cardiol Rev. 2013; 9:331–339.
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al.; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003; 42:1050–1065.
Aronow WS, Ahn C, Mercando AD, Epstein S. Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Cardiol. 2000; 86:1142–1143, A9.
Baber U, Mehran R. Coronary artery revascularization in chronic kidney disease: time for a randomized trial. Circ Cardiovasc Interv. 2015; 8:e002140.
Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006; 70:2021–2030.
Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006; 296:1377–1384.
Bangalore S, Maron DJ, O’Brien SM, Fleg JL, Kretov EI, Briguori C, et al.; ISCHEMIA-CKD Research Group. Management of coronary disease in patients with advanced kidney disease. N Engl J Med. 2020; 382:1608–1618.
Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011; 80:17–28.
Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014; 7:1–9.
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120:179–184.
Appleby CE, Ivanov J, Lavi S, Mackie K, Horlick EM, Ing D, et al. The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Circ Cardiovasc Interv. 2009; 2:309–316.
Lee JM, Kang J, Lee E, Hwang D, Rhee TM, Park J, et al. Chronic kidney disease in the second-generation drug-eluting stent era: pooled analysis of the Korean multicenter drug-eluting stent registry. JACC Cardiovasc Interv. 2016; 9:2097–2109.
Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998; 339:799–805.
Numasawa Y, Inohara T, Ishii H, Yamaji K, Hirano K, Kohsaka S, et al.; J-PCI Registry Investigators. An overview of percutaneous coronary intervention in dialysis patients: insights from a Japanese nationwide registry. Catheter Cardiovasc Interv. 2019; 94:E1–E8.
Tanios BY, Itani HS, Zimmerman DL. Clopidogrel use in end-stage kidney disease. Semin Dial. 2015; 28:276–281.
Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000; 15:218–223.
Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004; 44:1024–1030.
Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H, Bazari H, Palacios IF. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation. 2000; 102:2966–2972.
Mason PJ, Shah B, Tamis-Holland JE, Bittl JA, Cohen MG, Safirstein J, et al.; American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Council on Genomic and Precision Medicine. An update on radial artery access and best practices for transradial coronary angiography and intervention in acute coronary syndrome: a scientific statement from the American Heart Association. Circ Cardiovasc Interv. 2018; 11:e000035.
Rashid M, Kwok CS, Pancholy S, Chugh S, Kedev SA, Bernat I, et al. Radial artery occlusion after transradial interventions: a systematic review and meta-analysis. J Am Heart Assoc. 2016; 5:e002686.
Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, et al. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (mortality benefit of reduced transfusion after percutaneous coronary intervention via the arm or leg). Heart. 2008; 94:1019–1025.
Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson ED. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2008; 1:379–386.
Vora AN, Stanislawski M, Grunwald GK, Plomondon ME, Rumsfeld JS, Maddox TM, et al. Association between chronic kidney disease and rates of transfusion and progression to end-stage renal disease in patients undergoing transradial versus transfemoral cardiac catheterization-an analysis from the veterans affairs clinical assessment reporting and tracking (CART) program. J Am Heart Assoc. 2017; 6:e004819.
Cochran ST, Wong WS, Roe DJ. Predicting angiography-induced acute renal function impairment: clinical risk model. AJR Am J Roentgenol. 1983; 141:1027–1033.
Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol. 2004; 183:1673–1689.
Kroneberger C, Enzweiler CN, Schmidt-Lucke A, Rückert RI, Teichgräber U, Franiel T. Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease. Acta Radiol Open. 2015; 4:2058460115583034.
Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017; 389:1312–1322.
Bei W, Li H, Lin K, Wang K, Chen S, Guo X, et al.; TRUST investigators. Post-hoc study: intravenous hydration treatment in chinese patients with high risk of contrast-induced nephropathy following percutaneous coronary intervention. Sci Rep. 2017; 7:45023.
Liu Y, Hong D, Wang AY, Guo R, Smyth B, Liu J, et al. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2019; 19:87.
Luo Y, Wang X, Ye Z, Lai Y, Yao Y, Li J, Liu X. Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial. Intern Med. 2014; 53:2265–2272.
Wang Z, Song Y, A G, Li Y. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Int Heart J. 2019; 60:1077–1082.
Liu Y, Li H, Chen S, Chen J, Tan N, Zhou Y, et al. Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency. J Am Heart Assoc. 5:e003171.
Liu Y, Chen JY, Tan N, Zhou YL, Yu DQ, et al. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy. Circ Cardiovasc Interv. 2015; 8:e001859.
Liu Y, Chen JY, Huo Y, Ge JB, Xian Y, Duan CY, et al.; RESCIND group. Aggressive hydraTion in patients with ST-elevation myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (first study for reduction of contrast-induced nephropathy following cardiac catheterization) trial. Am Heart J. 2016; 172:88–95.
Chertow GM, Normand SL, McNeil BJ. “Renalism”: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol. 2004; 15:2462–2468.
Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006; 17:2937–2944.
Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007; 11:41–50.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150:604–612.
Teo BW, Koh YY, Toh QC, Li J, Sinha AK, Shuter B, et al. Performance of the CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equations in a multiethnic Asian population. Singapore Med J. 2014; 55:656–659.
Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002; 39:1113–1119.
Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003; 108:2769–2775.
تواريخ الأحداث: Date Created: 20201124 Date Completed: 20220124 Latest Revision: 20220124
رمز التحديث: 20221213
DOI: 10.1097/MCA.0000000000000980
PMID: 33229937
قاعدة البيانات: MEDLINE
الوصف
تدمد:1473-5830
DOI:10.1097/MCA.0000000000000980